Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nuclear Medicine and Biology|July 13, 2004
Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell deathJ Toretsky, A Levenson, I N Weinberg, et al.
Cancer Research|February 15, 1988
Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancersE R DeSombre, R C Mease, A Hughes, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1991
Production of no carrier added 80mBr for investigation of Auger electron toxicityR C Mease, O T DeJesus, S J Gatley, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Synthesis, purification and stability of no carrier added radioiodinated 1,1-bis(4-hydroxyphenyl)-2-iodo-2-phenylethylene (IBHPE), a prototype triphenylethylene estrogen-receptor binding radiopharmaceuticalS J Gatley, E R Desombre, R C Mease, et al.
Cancer Research|October 15, 1988
Bromine-80m radiotoxicity and the potential for estrogen receptor-directed therapy with auger electronsE R DeSombre, P V Harper, A Hughes, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic methodJ F Gestin, A Faivre-Chauvet, R C Mease, et al.
Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude miceA Faivre-Chauvet, J F Gestin, R C Mease, et al.
Nuclear Medicine Communications|September 1, 1996
Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibodyA Faivre-Chauvet, R C Mease, A Chetanneau, et al.
Scientific Reports|July 22, 2021
Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitorsO C Rogers, D M Rosen, L Antony, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2015
Prostate-specific membrane antigen as a target for cancer imaging and therapyA P Kiess, S R Banerjee, R C Mease, et al.
Pageof 2